Mobia Medical, Inc. is a commercial-stage medical device company redefining stroke recovery for survivors living with life-altering motor impairments. The Company’s Vivistim Paired Vagus Nerve Stimulation (Paired VNS) System is the clinically validated, FDA-approved solution for chronic ischemic stroke survivors with moderate to severe upper extremity impairments. The Vivistim System includes an implantable device that stimulates the vagus nerve only when intentionally activated, triggering the release of neuromodulators, including acetylcholine, norepinephrine, and serotonin. Its neuromodulators create a heightened state of plasticity in the brain, such that neural networks can more readily adapt and reform in response to stimuli. The implantable components of the Vivistim System-namely, the implantable pulse generator (IPG) and lead-are implanted through a minimally invasive outpatient procedure that takes approximately 60 minutes.
公司代碼MOBI
公司名稱Mobia Medical Inc
上市日期May 08, 2026
CEOFoust (Richard John)
員工數量- -
證券類型Ordinary Share
年結日- -
公司地址2802 Flintrock Trace, Suite 226
城市
上市交易所NASDAQ OMX - NASDAQ BASIC
國家United States of America
郵編78738
電話
網址
公司代碼MOBI
上市日期May 08, 2026
CEOFoust (Richard John)